What factors are predictive of survival in patients with non‐small‐cell lung cancer treated with gefitinib?
AUTOR(ES)
Archer, Kirsten
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2117302Documentos Relacionados
- Genome-Wide Analysis of Survival in Early-Stage Non–Small-Cell Lung Cancer
- Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
- Autotransplantation for Central Non-Small-Cell Lung Cancer in a Patient with Poor Pulmonary Function
- The expression of beta-catenin in non-small-cell lung cancer: a clinicopathological study.